$AAQL
Antiaging Quantum Living Inc.

2022 Q3 Form 10-Q Financial Statement

#000149315222022596 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $6.000K $2.400K $2.400K
YoY Change 233.33% 33.33% 33.33%
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $6.000K $2.400K $2.400K
YoY Change 400.0% 33.33% 33.33%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $7.520K $23.51K $6.060K
YoY Change -14.84% 45.03% -36.21%
% of Gross Profit 125.33% 979.58% 252.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00 $79.00 $40.00
YoY Change 166.67%
% of Gross Profit 1.33% 3.29% 1.67%
Operating Expenses $7.520K $23.51K $6.060K
YoY Change -14.84% 44.99% -36.21%
Operating Profit -$1.520K -$21.11K -$3.660K
YoY Change -80.08% 46.45% -52.47%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.520K -$21.11K -$3.660K
YoY Change -78.07% 55.89% -46.49%
Income Tax
% Of Pretax Income
Net Earnings -$1.520K -$21.11K -$3.660K
YoY Change -78.07% 55.89% -46.49%
Net Earnings / Revenue -25.33% -879.38% -152.5%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$50.68 -$703.80 -$122.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.300K $1.440K $14.27K
YoY Change -97.3% 11.63% -18.46%
Cash & Equivalents $1.301K $1.439K $14.27K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.301K $1.439K $14.27K
YoY Change -97.3% -97.29% -79.13%
LONG-TERM ASSETS
Property, Plant & Equipment $697.00 $775.00 $854.00
YoY Change -24.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $697.00 $775.00 $854.00
YoY Change -24.24%
TOTAL ASSETS
Total Short-Term Assets $1.301K $1.439K $14.27K
Total Long-Term Assets $697.00 $775.00 $854.00
Total Assets $1.998K $2.214K $15.12K
YoY Change -95.93% -95.82% -77.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $8.596K
YoY Change
Deferred Revenue $3.200K $3.200K $5.600K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $70.90K $61.00K $59.00K
YoY Change
Total Short-Term Liabilities $74.10K $72.80K $64.60K
YoY Change 1510.87% 0.27% -13.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $74.10K $72.80K $64.60K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $74.10K $72.80K $64.60K
YoY Change -1.98% 0.27% -13.17%
SHAREHOLDERS EQUITY
Retained Earnings -$262.3K -$260.8K -$239.7K
YoY Change
Common Stock $30.00K $30.00K $30.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$72.10K -$70.58K -$49.48K
YoY Change
Total Liabilities & Shareholders Equity $1.998K $2.214K $15.12K
YoY Change -95.93% -95.82% -77.88%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.520K -$21.11K -$3.660K
YoY Change -78.07% 55.89% -46.49%
Depreciation, Depletion And Amortization $80.00 $79.00 $40.00
YoY Change 166.67%
Cash From Operating Activities -$9.680K -$14.83K -$4.650K
YoY Change 110.43% -8.52% -51.05%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.580K
YoY Change -100.0%
Cash From Investing Activities $0.00 -$1.580K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.900K $2.000K 5.000K
YoY Change
NET CHANGE
Cash From Operating Activities -9.680K -$14.83K -4.650K
Cash From Investing Activities 0.000 -1.580K
Cash From Financing Activities 9.900K $2.000K 5.000K
Net Change In Cash 220.0 -$12.83K -1.230K
YoY Change -99.53% -20.86% -87.05%
FREE CASH FLOW
Cash From Operating Activities -$9.680K -$14.83K -$4.650K
Capital Expenditures $0.00
Free Cash Flow -$4.650K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001672571
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Depreciation
Depreciation
usd
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2022Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2021Q2 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
000-56157
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
Achison Inc
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
135-22 Northern Blvd.
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
2nd Fl
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
CY2022Q2 dei City Area Code
CityAreaCode
(917)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
470-5393
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1439 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14269 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1439 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
14269 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
775 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
854 usd
CY2022Q2 us-gaap Assets
Assets
2214 usd
CY2022Q1 us-gaap Assets
Assets
15123 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
61000 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
59000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8596 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
72796 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64600 usd
CY2022Q2 us-gaap Liabilities
Liabilities
72796 usd
CY2022Q1 us-gaap Liabilities
Liabilities
64600 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260807 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239702 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-70582 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2214 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15123 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2400 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1800 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2400 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
1800 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23505 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16211 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
23505 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
16211 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21105 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14411 usd
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
873 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
873 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21105 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13538 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13538 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-70582 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-6041 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13538 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-19579 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13538 usd
CY2022Q2 us-gaap Depreciation
Depreciation
79 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8596 usd
CY2021Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
873 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2400 usd
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1800 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14830 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16211 usd
CY2022Q2 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
2000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12830 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16211 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14629 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17496 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1439 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1285 usd
CY2022Q2 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zBp44ZF4iade" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260807 usd
CY2022Q2 ACHN Working Capital
WorkingCapital
-71357 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
61000 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
59000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21105 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43436 usd
CY2022Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
31323 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11945 usd

Files In Submission

Name View Source Status
0001493152-22-022596-index-headers.html Edgar Link pending
0001493152-22-022596-index.html Edgar Link pending
0001493152-22-022596.txt Edgar Link pending
0001493152-22-022596-xbrl.zip Edgar Link pending
achn-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
achn-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
achn-20220630_cal.xml Edgar Link unprocessable
achn-20220630_pre.xml Edgar Link unprocessable
achn-20220630_lab.xml Edgar Link unprocessable